Performance Stack vs Wolverine Stack
A side-by-side research comparison of Performance Stack and Wolverine Stack across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Performance Stack | Wolverine Stack |
|---|---|---|
| Full name | Performance (Follistatin-344 + IGF-1 LR3 + MGF + CJC/Ipa) | Wolverine (BPC-157 + TB-500 Combination) |
| Category | Popular Stacks | Popular Stacks |
| Status | Research stack | Research stack |
| Mechanism | Follistatin-344 binds and neutralizes myostatin, removing the genetic brake on muscle growth. IGF-1 LR3 activates Akt/mTOR for protein synthesis. MGF activates dormant satellite cells for muscle fiber addition. CJC-1295/Ipamorelin provides GH support for recovery and fat oxidation. | BPC-157 upregulates VEGF and promotes localized angiogenesis at injury sites. TB-500 upregulates actin expression, promoting cell migration and reducing inflammation systemically. The combination addresses both local and systemic repair pathways. |
| Molecular weight | Multiple compounds | BPC-157: 1419 Da + TB-500: 4921 Da |
| Half-life | Follistatin: ~2-4h, IGF-1 LR3: ~20-30h, MGF: ~5-7min, CJC/Ipa: ~30min/2h | BPC-157: ~4h, TB-500: ~6h |
| Bioavailability | All injectable: ~90-95% SC/IM | ~95% subcutaneous for both |
| Typical dose | Follistatin 100mcg + IGF-1 LR3 50mcg + MGF 200mcg post-workout + CJC 100mcg/Ipa 200mcg nightly | BPC-157 500mcg + TB-500 2.5mg |
| Frequency | Daily/post-workout | BPC-157 daily · TB-500 2x/week |
| Route | Subcutaneous/Intramuscular injection | Subcutaneous injection |
Performance Stack reported benefits
- Myostatin inhibition
- Enhanced protein synthesis
- Satellite cell activation
- Accelerated recovery
- Increased strength
- Lean mass gains
Wolverine Stack reported benefits
- Accelerated injury recovery
- Tendon and ligament repair
- Reduced systemic inflammation
- Improved flexibility
- Gut healing
- Post-surgical recovery
Related comparisons
Research and educational reference only. Not medical advice.